LH
LabcorpCOperating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
Peer overview
Broader but relevant diagnostics comparator: Abbott reported Q2 2026 sales of $12.6 billion, 13.3% comparable growth in Cancer Diagnostics, 7.5% U.S. Core Laboratory growth, and raised adjusted EPS guidance. Its diversified medical-device and pharmaceutical businesses reduce comparability. [Abbott Q2 2026 earnings](https://www.abbott.com/en-us/corpnewsroom/strategy-and-strength/abbotts-Q2-2026-earnings-call)
Grade position vs ABT
Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.

